These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31134194)

  • 21. Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?
    Boráň T; Menezes-Ferreira M; Reischl I; Celis P; Ferry N; Gänsbacher B; Krafft H; Lipucci di Paola M; Sladowski D; Salmikangas P
    Hum Gene Ther Clin Dev; 2017 Sep; 28(3):126-135. PubMed ID: 28510497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing medical technology innovation and clinical translation via a model of industry-enabled technical and educational support: Indiana Clinical and Translational Sciences Institute's Medical Technology Advance Program.
    Brightman AO; Coffee RL; Garcia K; Lottes AE; Sors TG; Moe SM; Wodicka GR
    J Clin Transl Sci; 2021 Jan; 5(1):e79. PubMed ID: 34007464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost.
    Shukla V; Seoane-Vazquez E; Fawaz S; Brown L; Rodriguez-Monguio R
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):102-113. PubMed ID: 30968714
    [No Abstract]   [Full Text] [Related]  

  • 26. The translation of product concept to bone products: a partnership of therapeutic effectiveness and commercialization.
    Ratcliffe A
    Tissue Eng Part B Rev; 2011 Dec; 17(6):443-7. PubMed ID: 21790510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RECOPE: How to succeed in bringing ideas from academia to market without compromising ingenuity.
    Gaymalov Z; Kabanov A
    Nanomedicine; 2017 Apr; 13(3):795-800. PubMed ID: 27989854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 30. The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products.
    Rafiq QA; Ortega I; Jenkins SI; Wilson SL; Patel AK; Barnes AL; Adams CF; Delcassian D; Smith D
    Regen Med; 2015 Nov; 10(8):989-1003. PubMed ID: 26628407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addressing challenges of training a new generation of clinician-innovators through an interdisciplinary medical technology design program: Bench-to-Bedside.
    Loftus PD; Elder CT; D'Ambrosio T; Langell JT
    Clin Transl Med; 2015; 4():15. PubMed ID: 25984273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal.
    Hettle R; Corbett M; Hinde S; Hodgson R; Jones-Diette J; Woolacott N; Palmer S
    Health Technol Assess; 2017 Feb; 21(7):1-204. PubMed ID: 28244858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approaches for Effective Clinical Application of Stem Cell Transplantation.
    Attico E; Sceberras V; Pellegrini G
    Curr Transplant Rep; 2018; 5(3):244-250. PubMed ID: 30221121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Market power in the United States red meatpacking industry.
    Koontz SR
    Vet Clin North Am Food Anim Pract; 2003 Jul; 19(2):519-44. PubMed ID: 12951745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe.
    Farkas AM; Mariz S; Stoyanova-Beninska V; Celis P; Vamvakas S; Larsson K; Sepodes B
    Front Med (Lausanne); 2017; 4():53. PubMed ID: 28560211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translating cell-based regenerative medicines from research to successful products: challenges and solutions.
    Bayon Y; Vertès AA; Ronfard V; Egloff M; Snykers S; Salinas GF; Thomas R; Girling A; Lilford R; Clermont G; Kemp P
    Tissue Eng Part B Rev; 2014 Aug; 20(4):246-56. PubMed ID: 24754565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translational science: past, present, and future.
    Curry SH
    Biotechniques; 2008 Feb; 44(2):ii-viii. PubMed ID: 18422489
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.